Classically, hydroxychloroquine (HCQ) impedes endosomal acidification and TLR7/9 signaling, reducing IFN-α and TNF production by pDCs upon TLR7/9 stimulation in SLE [370]. Here, IFNA2 is linked to systemic lupus erythematosus.